Jiang, X, Cao, C, Sun, W, Chen, Z, Li, X, Nahar, L, Sarker, SD, Georgiev, MI and Bai, W (2019) Scandenolone from Cudrania tricuspidata fruit extract supresses the viability of breast cancer cells (MCF-7) in vitro and in vivo. Food and Chemical Toxicology, 126. pp. 56-66. ISSN 0278-6915

Preview

Text Xinwei2019_FCT_AcceptedVersion.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (9MB) | Preview

Abstract

Scandenolone, an isoflavone, has shown anti-cancer potential. In this study, we extracted scandenolone from Cudrania tricuspidata fruit and evaluated its anti-breast cancer effects as well as toxicity in cell and animal models. In cell model, scandenolone suppressed the breast cancer MCF-7 cells viability, ceased mitotic cell cycle, decreased mitochondrial membrane potential, up-regulated cleaved caspase-3 and promoted the phosphorylation of p53. Additionally, this isoflavone promoted cell apoptosis and induced a sustained activation of the phosphorylation of p38 and ERK, but not JNK and Akt. The effects were further verified in a human MCF-7 breast cancer xenograft model, where scandenolone efficiently suppressed the cancer growth and increased apoptotic cells in tumor tissue. However scandenolone has also shown certain toxicity to normal hepatocytes and breast epithelial cells. It could be concluded that scandenolone suppressed the growth of breast cancer cells, but its toxicity towards normal cells might limit its potential clinical use.

Item Type:	Article
Uncontrolled Keywords:	0908 Food Sciences
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RV Botanic, Thomsonian, and eclectic medicine
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	Elsevier
Date Deposited:	15 Feb 2019 11:58
Last Modified:	04 Sep 2021 09:43
DOI or ID number:	10.1016/j.fct.2019.02.020
URI:	https://researchonline.ljmu.ac.uk/id/eprint/10167

View Item